Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 35 - Antineoplastic agents
Patents for A61P 35 - Antineoplastic agents (221,099)
10/2013
10/30/2013CN102440987B Drug compound of apigenin, apigenin-like derivants, artemisinin and artemisinin-like derivants and application thereof
10/30/2013CN102432866B Preparation method of prodrug of triptolide
10/30/2013CN102391095B Rheum emodin derivative and application thereof
10/30/2013CN102336764B Spin-labeling rotenone oxime ester, its preparation method and application
10/30/2013CN102276554B 4-((2-amino-5-sulfydryl-1,3,4-thiadiazole)-methyl)-benzamide derivative as well as preparation method and application thereof
10/30/2013CN102268005B Indole diketopiperazine alkaloid compound derived from tryptophan and proline and preparation method and application thereof
10/30/2013CN102268003B Unsymmetrical poly-substituted porphyrin gold (III) type anticancer compound and preparation method thereof
10/30/2013CN102260274B Preparation method and application of anticancer compound
10/30/2013CN102260271B Cytochalasin compound as well as preparation method thereof and purpose
10/30/2013CN102250105B Camptothecin derivatives, synthesis method thereof and use thereof
10/30/2013CN102247342B Application of alkyl isourea compound
10/30/2013CN102239164B 2H-chromene compound and derivative thereof
10/30/2013CN102219745B 2-aryl substituted benzimidazole derivatives, as well as preparation method and application thereof
10/30/2013CN102199121B 4-(4-(3-trifluoro methyl) benzamido phenoxyl)-2-(methyl carbamyl) pyridine salt, its preparation method and application
10/30/2013CN102145173B Human serum albumin complex hydrophobically modified pullulan nanoparticles and preparation method thereof
10/30/2013CN102108078B 1,4-substituted phthalazine compound and preparation method and applications thereof
10/30/2013CN102036667B Compositions comprising quinazoline derivatives, preparation methods and uses thereof
10/30/2013CN102028953B Compositions and methods for targeted in vitro and in vivo drug delivery to mammalian cells via bacterially derived intact minicells
10/30/2013CN101835770B Condensed compounds with activity at estrogen receptors
10/30/2013CN101768202B Preparing method of high purity sarsasapogenin in rhizoma anemarrhenae and derivatives thereof, and medical new application thereof
10/30/2013CN101766680B Comprehensive extraction method of glycyrrhiza
10/30/2013CN101677942B Intravesical apaziquone administration following transurethral resection for treating cancer
10/30/2013CN101676286B Azaindoles useful as inhibitors of JAK and other protein kinases
10/30/2013CN101641374B Binding members for interleukin-6
10/30/2013CN101605457B P-toluene sulfonic acid salt of 5-amino-3-(2'-o-acetyl-3'-deoxy-ss-d-ribofuranosyl)-3h-thiazole [4, 5-d] pyrimidine-2-one and methods for preparation
10/30/2013CN101591230B 2,4-dyhydroxyl chalcone derivative, preparation method and application thereof
10/30/2013CN101550185B Tumor-related gene or protein and application thereof
10/30/2013CN101535307B Triazole derivatives as kinase inhibitors
10/30/2013CN101506180B Human protein tyrosine phosphatase inhibitors and methods of use
10/30/2013CN101044242B Tumor specific antibody
10/29/2013US8569446 Peptides effective in the treatment of tumors and other conditions requiring the removal or destruction of cells
10/29/2013US8569347 Combination of epothilone analogs and chemotherapeutic agents for the treatment of proliferative diseases
10/29/2013US8569332 O-methylated rapamycin derivatives for alleviation and inhibition of lymphoproliferative disorders
10/29/2013US8569305 Treatment of tuberous sclerosis associated neoplasms
10/29/2013US8569286 Notch pathway signaling inhibitor compound
10/29/2013US8569280 Methods for the treatment of multiple myeloma
10/29/2013US8569058 Nerve regeneration promoters
10/29/2013US8568972 Substances causing differentiation
10/29/2013US8568799 Isolation of a dual COX-2 and 5-lipoxygenase inhibitor from acacia
10/29/2013CA2680825C Topical formulations having enhanced bioavailability
10/29/2013CA2636431C Steroidal compounds as steroid sulphatase inhibitors
10/29/2013CA2635691C Combination therapy with parp inhibitors
10/29/2013CA2612260C Apoptosis promoters
10/29/2013CA2606068C Pyrimidylaminobenzamide derivatives for hypereosinophilic syndrome
10/29/2013CA2594687C Use of pyrimidylaminobenzamides for the treatment of diseases that respond to modulation of tie-2 kinase activity
10/29/2013CA2562965C Nucleoside derivatives and therapeutic use thereof
10/29/2013CA2558615C Azabicyclo-octane inhibitors of iap
10/29/2013CA2477406C Dna vaccine against proliferating endothelial cells and methods of use thereof
10/29/2013CA2466128C Antibodies to cd40
10/29/2013CA2458001C Regulation of immune responses by manipulation of intermediary metabolite levels
10/29/2013CA2435672C Polypeptides capable of binding to cd64 and comprising one or more heterologous t cell epitopes, and their uses
10/29/2013CA2434643C Peptides for activation and inhibition of.delta.pkc
10/29/2013CA2396992C Hybrid cells
10/29/2013CA2375467C Antisense therapy for hormone-regulated tumors
10/24/2013WO2013159051A1 Morpholino-mediated increase in soluble flt-1 expression results in decreased ocular and tumor neovascularization
10/24/2013WO2013159026A1 Deuterated rigosertib
10/24/2013WO2013158984A1 Biomarkers to identify patients that will respond to treatment and treating such patients
10/24/2013WO2013158962A1 Imaging-aided gene therapy using mesenchymal stem cells as target-delivery vehicle
10/24/2013WO2013158952A1 Isoindolone derivatives
10/24/2013WO2013158800A1 Sodium channel sensitive conopeptides and analogs, including compositions and methods thereof
10/24/2013WO2013158617A1 Endostatin peptides and use thereof
10/24/2013WO2013158600A1 Multivalent peptoid oligomers, pharmaceutical compositions and methods of using same
10/24/2013WO2013158559A1 Inhibition of colony stimulating factor-1 receptor signaling for the treatment of brain cancer
10/24/2013WO2013158550A1 Metal-based thiophene photodynamic compounds and their use
10/24/2013WO2013158263A1 Replication-competent vesicular stomatitis viruses
10/24/2013WO2013158262A1 Ring constrained analogs as arginase inhibitors
10/24/2013WO2013158256A2 Immunomodulation by anti-cd3 immunotoxins to treat cancers not uniformly bearing surface cd3
10/24/2013WO2013158197A1 Marinopyrrole derivatives as anticancer agents
10/24/2013WO2013157889A1 Use of a novel aminopyridine derivative to prevent or treat cancer
10/24/2013WO2013157648A1 Pharmaceutical composition
10/24/2013WO2013157555A1 Novel aplysiatoxin derivative and anticancer agent containing same
10/24/2013WO2013157540A1 Nitrogen-containing heterocyclic compound or salt thereof
10/24/2013WO2013157410A1 Fzd10-binding peptide
10/24/2013WO2013157105A1 Mucin 5ac specific human antibody and use thereof
10/24/2013WO2013157102A1 Mucin 5ac specific human antibody and use thereof
10/24/2013WO2013157010A1 Methods and compositions for rnai-based cancer treatment
10/24/2013WO2013156989A1 Lipidated glycosaminoglycan particles for the delivery of nucleic acids
10/24/2013WO2013156920A1 Klotho variant polypeptides and uses thereof in therapy
10/24/2013WO2013156835A1 An improved process for the preparation of erlotinib hydrochloride form a
10/24/2013WO2013156780A1 Therapeutic compounds
10/24/2013WO2013156772A1 Crystalline forms of (s) -4-amino-n- (1- (4 - chlorophenyl) - 3 - hydroxypropyl) -1- (7h - pyrrolo [2, 3-d] pyrimidi n-4-yl) piperidine-4-carboxamide
10/24/2013WO2013156659A1 Antitumour activity of taiwaniaquinoids and related compounds
10/24/2013WO2013156473A1 Combination therapy of anti-mif antibodies and chemotherapeutics
10/24/2013WO2013155890A1 Antigen composition, preparation method and use thereof, and tumor vaccine
10/24/2013WO2013155885A1 Application of lucide ganoderma and ginseng medicinal mycoplasm in preparing drugs for treating lung cancer
10/24/2013WO2013155865A1 Method for increasing yield of total triterpene compounds in phellinus igniarius
10/24/2013WO2013155695A1 Isoindolone derivatives
10/24/2013WO2013155600A1 Fused aromatic phosphonate derivatives as precursors to ptp-1b inhibitors
10/24/2013WO2013134407A3 Procaspase 3 activation by combination therapy
10/24/2013WO2013134081A3 Halogenated compounds for photodynamic therapy
10/24/2013WO2013093508A3 Wnt pathway inhibitors
10/24/2013WO2013091883A3 Selective ligands for the angiotensin ii receptors
10/24/2013WO2013088250A4 Bacterially derived, intact minicells for delivery of therapeutic agents to brain tumors
10/24/2013WO2012136080A8 Benzomorpholine derivatives, preparation method and use thereof
10/24/2013US20130281704 Salts of benzimidazole compound and use thereof
10/24/2013US20130281522 Methods for alzheimer's disease treatment and cognitive enhancement
10/24/2013US20130281437 Method for cancer therapy
10/24/2013US20130281386 Glufosfamide Combination Therapies for Cancer
10/24/2013US20130280330 Microsphere drug carrier, preparation method, composition and use thereof
10/24/2013US20130280329 Methods and compositions for rnai-based cancer treatment
1 ... 121 122 123 124 125 126 127 128 129 130 131 132 133 134 135 136 137 138 139 140 141 ... 2211